SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 297 filers reported holding SEATTLE GENETICS INC in Q2 2018. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,389,000 | +104.6% | 16,266 | +35.6% | 0.07% | +111.4% |
Q4 2018 | $679,000 | -72.9% | 12,000 | -68.2% | 0.04% | -32.7% |
Q2 2018 | $2,502,000 | +80.6% | 37,700 | +45.6% | 0.05% | +160.0% |
Q4 2017 | $1,385,000 | -70.3% | 25,900 | -70.7% | 0.02% | -83.1% |
Q4 2016 | $4,670,000 | +1097.4% | 88,500 | +917.2% | 0.12% | +391.7% |
Q4 2015 | $390,000 | -65.9% | 8,700 | -70.7% | 0.02% | -72.1% |
Q3 2015 | $1,145,000 | +175.2% | 29,700 | +245.3% | 0.09% | +36.5% |
Q2 2015 | $416,000 | -53.2% | 8,600 | -55.9% | 0.06% | +50.0% |
Q1 2014 | $888,000 | +62.3% | 19,500 | +56.0% | 0.04% | -14.3% |
Q3 2013 | $547,000 | +47.4% | 12,500 | +5.9% | 0.05% | -24.6% |
Q2 2013 | $371,000 | – | 11,800 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |